Management of Cervical Spondylosis through Ayurveda

A Comparative Clinical Study to Evaluate the Efficacy of Nasya Karma with Mahamasha Taila and Greeva Parisheka with Dashamoola Kwath followed by Trayodashanga Guggulu in the management of Manyastambha with special reference to Cervical Spondylosis

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/12/022515

Enrollment

Registered

2019-12-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M479- Spondylosis, unspecified

Interventions

Intervention1: Nasya Karma: Mahamasha Taila for Nasya Karma for 14 days Control Intervention1: Greeva Parisheka: Greeva Parisheka with Sukhoshna Dashmoola Kwath for 30 minutes duration is planned for

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from classical signs and symptoms of Manyastambha vis-a-vis cervical spondylosis Patient willing and able to participate in the study for the entire trial period Patients fit for Nasya Karma and Greeva Parisheka

Exclusion criteria

Exclusion criteria: Patients suffering from any acute diseases/ infectious diseases/metabolic diseases/chronic diseases (like rheumatoid Arthritis, DM, Gout,TB, SLE, Ankylosing spondylitis etc) Patients with major systemic disorders that may interfere with the course of treatment Stenosis of Spinal Canal, Myelopathy Patients Unfit for Nasya Karma and Greeva Parisheka Patients having any cut/any skin disease over nape of neck

Design outcomes

Primary

Measure	Time frame
Assessment of changes in Pain (VAS)Timepoint: 60 days	—

Secondary

Measure	Time frame
Assessment of changes in Sthambha, Bhrama, NDI , ROMTimepoint: within trial period	—

Countries

India

Contacts

Public ContactDr Dinesh Sharma

National Institute of Ayurveda

dr.dineshkanav@gmail.com9417913271

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026